Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Hikma Pharmaceuticals (HIK) Share News

LONDON BRIEFING: NatWest profit rises; Deutsche Bank buys Numis

28th Apr 2023 07:53

(Alliance News) - Stocks in London were set to open higher on Friday, after a solid session for Asian equities and a strong finish in New York on Thursday. Read More

UK earnings, trading statements calendar - next 7 days

21st Apr 2023 15:51

Read More

LONDON MARKET OPEN: Stocks looking for direction before US inflation

12th Apr 2023 08:49

(Alliance News) - Stock prices in London opened mixed on Wednesday, as caution prevailed ahead of a US inflation reading and minutes from the Federal Reserve's March meeting. Read More

Hikma Pharmaceutical appoints Injectables lead Mishlawi as new CEO

12th Apr 2023 08:07

(Alliance News) - Hikma Pharmaceuticals PLC on Wednesday said it has appointed Riad Mishlawi as chief executive officer, effective September 1, allowing Said Darwazah to step down as acting CEO and return to his role as executive chair. Read More

LONDON BRIEFING: Anglo American's De Beers shines; Unite bookings up

12th Apr 2023 07:52

(Alliance News) - Stocks in London were called flat on Wednesday, with the focus for the day on a US inflation reading in the afternoon, before the release of central bank meeting minutes later. Read More

LONDON BROKER RATINGS: Goldman raises Spirent to 'neutral' from 'sell'

6th Apr 2023 09:20

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and Wednesday: Read More

UK dividends calendar - next 7 days

16th Mar 2023 15:50

Read More

LONDON BROKER RATINGS: JPMorgan cuts BAT; raises Bunzl

13th Mar 2023 09:40

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning: Read More

LONDON BROKER RATINGS: Liberum cuts National Express to 'sell'

9th Mar 2023 09:15

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning: Read More

LONDON BROKER RATINGS: DB cuts Reckitt; Jefferies likes Tesco

6th Mar 2023 09:48

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning: Read More

LONDON BROKER RATINGS: Canaccord says sell Future; Investec likes RWS

1st Mar 2023 09:52

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning: Read More

LONDON BROKER RATINGS: Citi cuts Quilter to 'sell'; Goldman likes GSK

27th Feb 2023 09:26

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday: Read More

LONDON BROKER RATINGS: SocGen cuts Burberry; BofA cuts WH Smith

24th Feb 2023 09:37

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning and Thursday: Read More

Hikma Pharmaceuticals profit halves in 2022 on Generics impairment

23rd Feb 2023 09:54

(Alliance News) - Hikma Pharmaceuticals PLC on Thursday reported a dip in annual revenue for 2022, as profit tumbled due to high inflation and adjustments regarding expectations for its Generics business. Read More

LONDON MARKET OPEN: Mixed open in London; Rolls-Royce up, Mondi down

23rd Feb 2023 09:02

(Alliance News) - Stock prices in London opened mixed on Thursday, with large-cap indices underperforming amid mixed corporate earnings. Read More

LONDON BRIEFING: WPP profit jumps in 2022; guides for further growth

23rd Feb 2023 07:56

(Alliance News) - Stocks in London were called to open slightly higher on Thursday, as investors were unfazed by a fairly uneventful set of policy meeting minutes from the US central bank. Read More

UK earnings, trading statements calendar - next 7 days

16th Feb 2023 15:49

Read More

LONDON BROKER RATINGS: Goldman likes UK banks; HSBC cuts Dr Martens

25th Jan 2023 09:33

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning: Read More

Arecor transfers AT307 drug to Hikma for development, regains AT282

12th Jan 2023 17:55

(Alliance News) - Arecor Therapeutics PLC on Thursday said it transferred development activities for the ready-to-use injectable medicine AT307 to Hikma Pharmaceuticals PLC, and regained rights on AT282 after a product portfolio review. Read More

Hikma launches version of Xyrem medicine in US for treating narcolepsy

3rd Jan 2023 09:25

(Alliance News) - Hikma Pharmaceuticals PLC on Tuesday said it launched an authorised generic version of the Xyrem sodium oxybate prescription medicine in the US for treating narcolepsy. Read More

FTSE 100 Latest
Value9,228.11
Change19.74